Latest blood clots Stories
With Over 150 AndroGel Lawsuits Pending In The U.S., A Class Action Testosterone Therapy Lawsuit Has Been Filed In Canada Contending AbbVie Failed To Disclose The Health Risks Associated With
The FDA Is Seeking Input From Its Advisory Panels As Testosterone Lawsuits Mount And Reports That Low Testosterone Medication Purportedly Cause Heart Attacks And Strokes Reports Wright & Schulte
Attorney Ronald E. Johnson, Jr. has been appointed co-lead counsel in nationwide lawsuits for men injured by testosterone medications, like AndroGel.
The FDA Has Changed the Medication Guide for the Testosterone Therapy Drug AndroGel to Include The Risks of Blood Clots in the Legs and Lungs as Testosterone Treatment Lawsuits Rise to 156 Filings
With Over 100 Testosterone Lawsuits Awaiting Litigation in the U.S., Health Canada Has Issued A Safety Review Warning of Possible Cardiac Risks Associated With Testosterone Treatment Drugs
Required Change Reflects Reports of Additional Clotting Not Related to Condition Covered by Current Warnings DALLAS (PRWEB) July 17, 2014 The U.S.
The Number of Testosterone Treatment Lawsuits Filed Alleging Heart Attacks, Strokes, And Other Cardiac Events Were Due To Testosterone Therapy Drugs Such as AndroGel and Androderm Has Grown to
FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S.
The US Food and Drug Administration (FDA) is now requiring manufacturers of testosterone supplements to include a general warning label about the risk of blood clots in the veins.
With over 100 Testosterone Treatment Lawsuits Pending Litigation, The FDA Continues Its Investigation Into The Potential Health Risks of Testosterone Replacement Therapy Drugs Reports Wright &
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.